LeMaitre Vascular, Inc. (LMAT) Q2 2015 Earnings Results

Lemaitre Vascular IN (LMAT) Beats on EPS, Stock Up 0.27%

This earnings report indicates that Lemaitre Vascular has managed to exceed EPS expectations, which is a positive sign for investors. The stock's slight increase of 0.27% suggests that the market reacted favorably to the earnings surprise. However, the lack of revenue data and guidance leaves some uncertainty about the company's future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.10	N/A	+42.86%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding the company's performance. They noted that while EPS exceeded expectations, they did not provide specific revenue figures.

Management expressed satisfaction with the EPS performance despite the lack of revenue data.

They highlighted ongoing efforts to improve operational efficiency.

Lemaitre Vascular IN (LMAT) Beats on EPS, Stock Up 0.27%

Key numbers

Management commentary

LeMaitre Vascular, Inc.

More earnings this week

Lemaitre Vascular IN (LMAT) Beats on EPS, Stock Up 0.27%

Key numbers

Management commentary